Show simple item record

dc.contributor.authorde Mestier, L
dc.contributor.authorDromain, C
dc.contributor.authorLamarca, Angela
dc.contributor.authorLa Salvia, A
dc.contributor.authorOp de Beeck, B
dc.contributor.authorFehrenbach, U
dc.contributor.authorPusceddu, S
dc.contributor.authorColao, A
dc.contributor.authorBorbath, B
dc.contributor.authorde Haas, R
dc.contributor.authorRuszniewski, P
dc.contributor.authorVullierme, MP
dc.date.accessioned2020-06-15T12:57:36Z
dc.date.available2020-06-15T12:57:36Z
dc.date.issued2020en
dc.identifier.citationde Mestier L, Dromain C, Lamarca A, La Salvia A, Op de Beeck B, Fehrenbach U, et al. Proposal of new imaging criteria for evaluating the response of liver metastases to systemic treatments in digestive neuroendocrine tumors (NET) as an alternative to RECIST 1.1. Neuroendocrinology. 2020;110:163-en
dc.identifier.urihttp://hdl.handle.net/10541/622957
dc.language.isoenen
dc.titleProposal of new imaging criteria for evaluating the response of liver metastases to systemic treatments in digestive neuroendocrine tumors (NET) as an alternative to RECIST 1.1en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentBeaujon Hospital, Clichy, Franceen
dc.identifier.journalNeuroendocrinologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record